Positioning psychiatric pharmacists to improve mental health care
- PMID: 35582321
- PMCID: PMC9009818
- DOI: 10.9740/mhc.2022.04.077
Positioning psychiatric pharmacists to improve mental health care
Abstract
Psychiatric pharmacy continues to grow and look to the future with a focus on helping individuals recover from mental health and substance use disorders. The American Association of Psychiatric Pharmacists (AAPP) considers Board Certified Psychiatric Pharmacist (BCPP) the gold standard credential that all psychiatric pharmacists should attain to demonstrate specialized knowledge and expertise in psychiatry. BCPPs are part of collaborative interprofessional teams and practice in hospitals, clinics, and diverse health systems. Two out of 3 BCPPs practicing in clinics have prescriptive authority. BCPPs improve access, safety, medication adherence, and therapeutic outcomes. Every person with a mental health and substance use disorder should have access to a BCPP providing comprehensive medication management (CMM) and psychotropic stewardship aimed at improving population health. BCPPs are in demand owing to their expertise. AAPP envisions growth and expansion of the BCPP role in many areas including coordinating psychiatric transitions of care and telehealth services, managing long-acting injectable medication clinics, providing pharmacogenomic consultation, conducting clozapine and lithium monitoring, managing medications for substance use disorders, leading medication groups, CNS drug development, research, and provider education. To prepare the workforce, colleges and schools of pharmacy should hire BCPPs for optimal curriculum development, and each student pharmacist should have an opportunity to develop a therapeutic alliance with a person recovering from psychiatric illness. Postgraduate year (PGY) 1 residencies should offer learning experiences in psychiatric pharmacy to prepare residents to enter an expanded number of PGY2 psychiatric pharmacy residencies, ultimately earning their BCPP and being well positioned to improve mental health care.
Keywords: mental health; pharmacist; profession; psychiatric; vision.
© 2022 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists.
Conflict of interest statement
Disclosures: The authors have no financial conflicts of interest related to this manuscript.
Figures

Similar articles
-
Board-Certified Psychiatric Pharmacists and Their Potential Role in Addressing Behavioral Health Workforce Shortages.Psychiatr Serv. 2024 Oct 1;75(10):1039-1041. doi: 10.1176/appi.ps.20230303. Epub 2024 Mar 27. Psychiatr Serv. 2024. PMID: 38532688
-
Psychotropic stewardship: Advancing patient care.Ment Health Clin. 2023 Apr 12;13(2):36-48. doi: 10.9740/mhc.2023.04.036. eCollection 2023 Apr. Ment Health Clin. 2023. PMID: 37063939 Free PMC article.
-
The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes.Psychiatr Serv. 2021 Jul 1;72(7):794-801. doi: 10.1176/appi.ps.202000066. Epub 2021 May 4. Psychiatr Serv. 2021. PMID: 33940946
-
The Role of the Pharmacist on an Inpatient Child and Adolescent Psychiatry Unit.Child Adolesc Psychiatr Clin N Am. 2025 Jan;34(1):1-12. doi: 10.1016/j.chc.2024.07.010. Epub 2024 Sep 27. Child Adolesc Psychiatr Clin N Am. 2025. PMID: 39510642 Review.
-
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.Pharmacy (Basel). 2021 Aug 21;9(3):146. doi: 10.3390/pharmacy9030146. Pharmacy (Basel). 2021. PMID: 34449724 Free PMC article. Review.
Cited by
-
Evaluation of workload among Board-Certified Psychiatric Pharmacists in the United States.Ment Health Clin. 2025 Jun 2;15(3):156-163. doi: 10.9740/mhc.2025.06.156. eCollection 2025 Jun. Ment Health Clin. 2025. PMID: 40496009 Free PMC article.
-
Ambitious AAPP vision necessitates bold actions.Ment Health Clin. 2022 Apr 14;12(2):86-88. doi: 10.9740/mhc.2022.04.086. eCollection 2022 Apr. Ment Health Clin. 2022. PMID: 35530259 Free PMC article. No abstract available.
-
Pharmacist-social worker interprofessional relations and education in mental health: a scoping review.PeerJ. 2024 Feb 23;12:e16977. doi: 10.7717/peerj.16977. eCollection 2024. PeerJ. 2024. PMID: 38410797 Free PMC article.
-
Pharmacist administration of long-acting injectable medications for substance use disorders: A scoping review.Ment Health Clin. 2025 Feb 3;15(1):17-24. doi: 10.9740/mhc.2025.02.017. eCollection 2025 Feb. Ment Health Clin. 2025. PMID: 39974754 Free PMC article. Review.
-
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects.Ther Adv Drug Saf. 2023 Dec 6;14:20420986231213173. doi: 10.1177/20420986231213173. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 38074415 Free PMC article.
References
-
- Stoner SC, Ott CA, DiPaula BA. Psychiatric pharmacy residency training. Am J Pharm Educ. 2010;74(9):163. 10.5688/aj7409163 PubMed PMID: 21301597. - DOI - PMC - PubMed
-
- College of Psychiatric and Neurologic Pharmacists [Internet] About CPNP. Lincoln, NE: CPNP [cited; 2022. Feb 21]. Available from: https://cpnp.org/about.
-
- Goldstone LW, Dipaula BA, Werremeyer A, Botts S, Hepburn B, Liu HY, et al. The role of board-certified psychiatric pharmacists in expanding access to care and improving patient outcomes. Psychiatr Serv. 2021;72(7):794–801. 10.1176/appi.ps.202000066 PubMed PMID: 33940946. - DOI - PubMed
LinkOut - more resources
Full Text Sources